Lifibrate

DB21399ExperimentalSmall molecule

Lifibrate is a small molecule drug. The usage of the INN stem '-fibrate' in the name indicates that Lifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. Lifibrate... Lifibrate has a monoisotopic molecular weight of 409.08 Da.

Mechanism: Pharmacologically active on Cholinephosphotransferase 1
Curator reviewed
Formula / weight: C₂₀H₂₁Cl₂NO₄ · 410.29 g/mol (avg)
Code names: 42-348

Resolves to

Compound

UNIIY4X961F8Z1CAS22204-91-7ChEMBLCHEMBL1883563

Structure

InChIKeyQDGIAPPCJRFVEK-UHFFFAOYSA-NSMILESCN1CCC(CC1)OC(=O)C(OC1=CC=C(Cl)C=C1)OC1=CC=C(Cl)C=C1

Targets

Q8WUD6CHPT1

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Lifibrate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account